期刊文献+

多色荧光原位杂交在膀胱癌诊断及监测中的意义 被引量:3

The Significance of Multicolor Fluorescence in Situ Hybridization in Diagnosis and Monitoring of Bladder Cancer
原文传递
导出
摘要 目的:探讨通过多色荧光原位杂交(multicolor fluorescence in situ hybridization,M-FISH)技术检测3、7、9、17号染色体数目畸变诊断膀胱移行细胞癌(bladder transition cell carcinoma,BTCC)的可行性和有效性。方法:采用3、7、17号染色体着丝粒探针和9p21区带探针对46例BTCC患者、15例非肿瘤患者和5例正常人尿液脱落细胞核行M-FISH检测,并同时行尿脱落细胞学(urinary cytological examination,UCE)检查,比较其敏感性和特异性,并分析各条染色体畸变与肿瘤恶性程度的相关性。结果:①M-FISH和UCE的灵敏度分别为73.9%(34/46)、47.8%(22/46),两者比较P<0.05;特异度分别为95.0%、100%,两者比较P>0.05。②MFISH在肿瘤临床分期T_a-T_1、T_2~T_(?)的阳性率分别为50.0%、84.4%;病理分级G_1、G_2、G_3的阳性率分别为42.9%、80.0%、100%,其阳性率与BTCC分级分期呈正相关(P<0.05)。③3、7、17号染色体在BTCC的畸变率分别为71.7%、73.9%、73.9%,其畸变率与肿瘤分期分级呈正相关(P<0.05)。9号染色体畸变率为56.5%,与分级分期无明显相关性(P≥0.05)。结论:使用M-FISH技术检测尿脱落细胞3、7、9、17号染色体数目畸变具有敏感度高、特异性强的优点,并具无创性,对BTCC的诊断具有重要的临床应用价值。 Objective:To evaluate the possibility and validity of detecting numerical aberration of chromosomes 3, 7, 9 and 17 by multicolor fluorescence in situ hybridization (M-FISH) in order to diagnose bladder transition cell carcinoma(BTCC). Methods: Some volunteers were recruited as subjects, including 46 patients suffering from BTCC, 15 non-tumor patients, and 5 healthy individuals. Exfoliated cells from fresh urinary specimen was eollected and examined by M-FISH using centromeric probes of chromosome 3, 7, 17 and region probe of 9p21. Urinary cytological examination (UCE) was applied at the same time. The sensitivity and specificity of each method in the diagnosis of bladder cancer were determined and various chromosomal aberrations and malignant degree of correlation by comparative analysis. Results:(1) The sensitivity of M FISH and UCE were 73.9%, 47.8%, respectively. Comparison between the two(P〈0.05), The specificity of M-FISH and UCE were 95.0%, 100% , respectively. Comparison between the two(P〉0.05) ,. (2) The positive rate of M-FISH in T0-T1 and T2-T4 patients were 50. 0% ,84.4%, respectively. The positive rate of M-FISH in G1 , G2, G3 patients Were 42.9%, 80.0%, 100%, respectively. The positive rate was positively associated with the clinical stage and pathological grade (P〈0.05). (3) The frequency of numerical aberration of chromosomes 3, 7, 9,and 17 were 71.7% ,73.9%0,56.5%, and 73.9% in urinary exfoliated cells, respectively. Abnormality of chromosomes 3, 7and 17 was positively associated with the clinical stage and pathological grade(P〈0.05), but aberration of chromosomes 9 was not correlated with pathological grade of cancer and stage of the disease (P≥0.05). Conclusions:The sensitivity and specificity of M-FISH detecting 3, 7, 9, 17 chromosome aherrationns are high in the diagnosis of bladder cancer. It is a rapid, noninvasive, accurate and very sensitive method and can be used in clinical diagnosis and monitoring of post-operative patients.
出处 《临床泌尿外科杂志》 北大核心 2010年第4期245-249,共5页 Journal of Clinical Urology
关键词 膀胱癌 多色荧光原位杂交技术 染色体畸变 分子细胞遗传学 bladder cancer multicolor fluorescence in situ hybridization aberration of chromosomes molecular cell genetics
  • 相关文献

参考文献3

二级参考文献26

  • 1乔忠杰,王国民.膀胱癌复发与染色体畸变关系的研究进展[J].国外医学(泌尿系统分册),2005,25(2):167-170. 被引量:5
  • 2张业贵,毕新刚,韩亚玲,蔡岩,徐昕,吴玉鹏,杨壹羚,马建辉,赵平,贾雪梅,王明荣.多色荧光原位杂交在膀胱尿路上皮癌诊断中的应用[J].癌症,2007,26(2):189-193. 被引量:27
  • 3Kipp BR, Karnes RJ, Brankley SM, et al. Monitoring intravesical therapy for superficial bladder cancer using fluorescence insitu hybridization[J]. J Urol,2005,173:401.
  • 4Gallucci M, Guadagni F, Marzano R, et al. Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7,9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters[J]. J Clin Pathol, 2005,58(4) : 367-371.
  • 5Kruger S, Mess F, Bohle A, et al. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder[J]. Int J Oncol,2003,23(1) :41-48.
  • 6Mhawech-Fauceglia P, Fischer G, Beck A, et al. Raf1,Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma: a retrospective TMA study of 246 patients with long-term follow-up [J]. Eur J Surg Oncol,2006,32(4) :439-444.
  • 7全国肿瘤防治研究办公室.卫生部统计信心中心.中国试点县、市恶性肿瘤的发病与死亡[M].北京:中国医药科技出版社,2002:24—34.
  • 8Prout G R Jr, Barton B A, Griffin P P, et al. Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group [J]. J Urol, 1992,148 (5):1413-1419.
  • 9Raitanen M P, Kaasinen E, Lukkarinen O, et al. Analysis of false-positive BTA STAT test results in patients followe dup for bladder cancer [J]. Urology, 2001,57(4) :680-684.
  • 10Inoue T, Nasu Y, Tsushima T, et al. Chromosomal numerical aberrations of exfoliated cells in the urine detected by fluorescence in situ hybridization: clinical implication for the detection of bladder cancer [J]. Urol Res, 2000,28(1):57-61.

共引文献37

同被引文献51

  • 1Sarosdy MF,Schel lhammer P,Bokins ky G,et al.Clinical evaluation of a multitarget fluorescent in situ hybridization assay for detection of bladder cancer[J].J Urol,2002,168(5):1950-1954.
  • 2Mengual L,Mercedes MA,Mara JR,et al.Clinical utilit y of fluorescent in situ hybridization f or the surveillance of bladder cancer patients treated with bacillus calmette gurin therapy[J].EurUrol, 2007, 52(3): 752-759.
  • 3Marek Skacel,Ana Siva.From array to array:Confirmation of genomic gains and losses discovered by array-based comparative genomic hybridization utilizing fluorescence in situ hybridization on tissue microarrays[ J]. J Mol Hist,2007, 38 : 135 - 140.
  • 4Yoshimoto M,Cutz JC,Nuin PA,et al.Interph as e FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high grade prostatic intra epithelial neoplasias [ J]. Cancer Genetcytogenet , 2006, 169(2) : 128-137.
  • 5Yoshimoto M,Cunha IW.FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome[J].Br J Cancer,2007,97(5):678-685.
  • 6Reid AH,Attard G.Molecular characterisation of ERG,ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer[J].Br J Cancer,2010,102(4):678-684.
  • 7Tomlins SA,Rhodes DR,Perner S,et al.Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer[J].Science,2005,310(5748):644-648.
  • 8Sun QP,Li LY,Chen Z,et al.Detection of TMPRSS2-ETS fusions by a multiprobe fluorescence in situ hybridization assay for the early diagnosis of prostate cancer:a pilot study[J].J Mol Diagn,2010.12(5) :718 -724.
  • 9Petrovics G,Liu A,Shaheduzzaman S,et al.Frequent overexpression of ETS related gene1 (ERG1) inprostate cancer transcriptome[J].Oncogene,2005,24(23):3847-3852.
  • 10Sanjmyatav J,Rubtsov N,Starke H,et al.Identification of tumor entities of renal cell carcinoma using interphase fluorescence in situ hybridization[J] ].2005,174(2):731-735.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部